Advanced or Metastatic Solid Tumor Malignancies

1

Review clinical trials related to Advanced or Metastatic Solid Tumor Malignancies. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

The purpose of this study is to assess the safety and tolerability of GIGA-564 and identify the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) level(s) of GIGA-564 in participants with metastatic or locally advanced solid tumor malignancies.

Participants needed: 60
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: GigaGen, Inc.Updated: Apr 10, 2025Locations: 1
Eligibility criteria

Willing and able to provide informed consent. [+14]

Investigational therapy and/or anti-cancer therapy with the potential for late o... [+19]